Related Experiment Videos
Giant cell arteritis-a systemic spectrum including temporal arteritis and polymyalgia rheumatica
The Journal of Family Practice
|December 1, 1978
Summary
Polymyalgia rheumatica and giant cell arteritis are common in the elderly. Early diagnosis and corticosteroid treatment can prevent serious complications like blindness and stroke.
Area of Science:
- Rheumatology
- Internal Medicine
- Geriatrics
Background:
- Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are closely linked inflammatory disorders.
- These conditions pose significant health risks to the elderly population.
- Their exact causes are unknown, but they may be different manifestations of a single underlying disease.
Purpose of the Study:
- To highlight the association between PMR and GCA.
- To emphasize the importance of early diagnosis and treatment in the elderly.
- To discuss potential pathogenetic mechanisms and clinical presentations.
Main Methods:
- Review of current evidence on PMR and GCA pathogenesis.
- Discussion of clinical manifestations, including subtle and atypical presentations.
- Emphasis on diagnostic challenges and the role of clinical suspicion.
Main Results:
- Autoimmune involvement of the internal elastic lamina in arteries is a potential key factor.
- Genetic and environmental factors may also play a role.
- PMR and GCA can have varied and sometimes subtle symptoms, leading to diagnostic delays.
Conclusions:
- Prompt diagnosis and corticosteroid therapy are crucial for preventing severe outcomes such as disability and vascular events.
- Family physicians play a vital role in identifying these conditions early.
- Despite diagnostic challenges, PMR and GCA are treatable rheumatological diseases.